CN1723919A - Medicine for treating urinary system stone disease, and its prepn. method - Google Patents
Medicine for treating urinary system stone disease, and its prepn. method Download PDFInfo
- Publication number
- CN1723919A CN1723919A CNA2005100440549A CN200510044054A CN1723919A CN 1723919 A CN1723919 A CN 1723919A CN A2005100440549 A CNA2005100440549 A CN A2005100440549A CN 200510044054 A CN200510044054 A CN 200510044054A CN 1723919 A CN1723919 A CN 1723919A
- Authority
- CN
- China
- Prior art keywords
- medicine
- radix
- urinary system
- medicated powder
- calculus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A Chinese medicine in the form of pills for treating stone in urinary system is prepared from 13 Chinese-medicinal materials including rhubarb, earthworm, talc, desmodium, etc. Its preparing process is also disclosed. Its advantages are high curative effect, no toxic by-effect and low cost.
Description
Technical field
The present invention relates to a kind of medicine nephrolith with Chinese medicine composition, treatment urinary system (kidney, ureter, bladder, urethra etc.) calculus wears.
Background technology
Urinary system calculus is common clinical, frequently-occurring disease, belongs to stranguria, stranguria caused by urinary stone, lumbago, the stomachache category of motherland's medical science.The clinical types such as renal calculus, ureteral calculus, vesical calculus, calculus of urethra that are divided into.All with the waist angina abdominis, pain is drawn the performances such as urgency, hematuria or the interruption of urinating frequently of external genitalia, urine during morbidity.And the treatment urinary system calculus medicine that adopts at present both at home and abroad mostly is chemical drugs, injures patient's vitals such as liver, kidney, stomach to some extent, causes serious medicine source property complication; Still do not have specific medicine at home, the state of an illness further develops and then forms renal failure end stage---uremia eventually, even causes death.As adopt operative treatment, make the patient bear the hardship of pain on the one hand; Bear the tremendous economic burden on the one hand, have a strong impact on patient's physical and mental health.
Summary of the invention
The objective of the invention is to develop better motherland's medicine and pharmacology, exploitation traditional Chinese medicines resource, utilizing natural plants---medicine provides a kind of medicine nephrolith for the treatment of urinary system calculus to wear for the treatment urinary system calculus, and it has characteristics such as clinical efficacy height, safe and reliable, easy to use, reasonable price.
The present invention is for achieving the above object, and the technical scheme of taking is: be the basis according to motherland's theory of medicine, absorb the modern medicine study elite, in conjunction with clinical experience for many years, according to monarch, the minister of Chinese medicine, help, make combination principle to allocate to form.With clearing away heat-damp and promoting diuresis, fossil calculus medicine is monarch drug, is aided with that to remove damp-heat in lower-JIAO, dispel the sandstone origin cause of formation be ministerial drug, is adjuvant drug and is messenger drug with heat-clearing and toxic substances removing, the property of medicine medicine that is in harmonious proportion with blood circulation promoting and blood stasis dispelling, broken hard eliminating stagnation medicine.
Medicine of the present invention is formed, and by its weight ratio is: Endothelium Corneum Gigeriae Galli 4800～5600g, Spora Lygodii 1500～2000g, Radix Et Rhizoma Rhei 1500～2000g, Pheretima 3000～3500g, Talcum 1500～2000g, Herba Lysimachiae 4800～5600g, Semen Plantaginis 1500～2000g, Folium Pyrrosiae 1500～2000g, Herba Salviae Chinensis 1500～2000g, Squama Manis 1500～2000g, Semen Vaccariae 1500～2000g, Rhizoma Alismatis 1500～2000g, Radix Glycyrrhizae 1500～2000g.
Medicine optimization of the present invention is formed, and by its weight ratio is: Endothelium Corneum Gigeriae Galli 4900～5200g, Spora Lygodii 1600～1800g, Radix Et Rhizoma Rhei 1600～1800g, Pheretima 3200～3400g, Talcum 1600～1800g, Herba Lysimachiae 4900～5200g, Semen Plantaginis 1600～1800g, Folium Pyrrosiae 1600～1800g, Herba Salviae Chinensis 1600～1800g, Squama Manis 1600～1800g, Semen Vaccariae 1600～1800g, Rhizoma Alismatis 1600～1800g, Radix Glycyrrhizae 1600～1800g.
Endothelium Corneum Gigeriae Galli, Pheretima, Talcum are monarch drug in the medicine, have clearing away heat-damp and promoting diuresis, the effect of fossil urinary calculus removing; Herba Lysimachiae, Spora Lygodii, Herba Salviae Chinensis, Folium Pyrrosiae, Semen Plantaginis are auxilliary, have the effect of eliminating damp-heat in lower-JIAO, dispeling the formation calculus origin cause of formation; Semen Vaccariae, Squama Manis, Rhizoma Alismatis, Radix Et Rhizoma Rhei are assistant, the blood circulation promoting and blood stasis dispelling of holding concurrently on the basis of clearing away heat-damp and promoting diuresis, broken hard eliminating stagnation; The Radix Glycyrrhizae heat-clearing and toxic substances removing also is in harmonious proportion the property of medicine for making; All medicines share have clearing away heat-damp and promoting diuresis, the effect of fossil calculus.
Manufacture method of the present invention: each is formed medicine and is equipped with by its weight ratio, will Endothelium Corneum Gigeriae Galli, be ground into fine powder behind the Spora Lygodii, Radix Et Rhizoma Rhei three flavor medicines oven dry, and mix homogeneously sieves with≤100 mesh sieves, produces medicated powder I, and is standby.Getting decoctings such as Pheretima, Talcum, Herba Lysimachiae, Semen Plantaginis, Folium Pyrrosiae, Herba Salviae Chinensis, Squama Manis, Semen Vaccariae, Rhizoma Alismatis, Radix Glycyrrhizae boils 2 times; First decocts 2～3h, filters; Second decocts 1～1.5h, filters; Merge 2 times filtrate, become the thick paste shape,, sieve, produce medicated powder II with≤200 mesh sieves with pulverizing behind the thick paste vacuum normal temperature drying at concentrating under reduced pressure below 80C °.Again medicated powder I, medicated powder II mixing are got final product with the general one-tenth watered pill of cold boiled water.
Urinary system calculus is common clinical, frequently-occurring disease, categories such as the stranguria of genus motherland medical science, stranguria caused by urinary stone, lumbago, stomachache.Its etiology and pathogenesis is mainly " damp-heat in lower-JIAO pents up, and decocts urine, accumulates over a long period, and becomes sandstone ".According to its etiology and pathogenesis, throw clearing away heat-damp and promoting diuresis, the key medicine of fossil calculus is the act that shoots the arrow at the target.Endothelium Corneum Gigeriae Galli, Pheretima, Talcum have clearing away heat-damp and promoting diuresis in the side, and the fossil urinary calculus removing act as monarch; Herba Lysimachiae, Spora Lygodii, Herba Salviae Chinensis, Folium Pyrrosiae, Semen Plantaginis are removed damp-heat in lower-JIAO, dispel the sandstone origin cause of formation, and it is auxilliary assisting monarch drug to play a role; Semen Vaccariae, Squama Manis, Rhizoma Alismatis, Radix Et Rhizoma Rhei are adjuvant drug, the blood circulation promoting and blood stasis dispelling of holding concurrently on the basis of clearing away heat-damp and promoting diuresis, broken hard eliminating stagnation; Radix Glycyrrhizae heat-clearing and toxic substances removing and coordinating the actions of various ingredients in a prescription are for making.Therefore the present invention has characteristics such as clinical efficacy height, safe and reliable, easy to use, reasonable price.
The specific embodiment
Medicine of the present invention is formed, and by its weight ratio is: Endothelium Corneum Gigeriae Galli 4900～5200g, Spora Lygodii 1600～1800g, Radix Et Rhizoma Rhei 1600～1800g, Pheretima 3200～3400g, Talcum 1600～1800g, Herba Lysimachiae 4900～5200g, Semen Plantaginis 1600～1800g, Folium Pyrrosiae 1600～1800g, Herba Salviae Chinensis 1600～1800g, Squama Manis 1600～1800g, Semen Vaccariae 1600～1800g, Rhizoma Alismatis 1600～1800g, Radix Glycyrrhizae 1600～1800g.
Medicine manufacture method of the present invention: after earlier various medicines being equipped with by its weight ratio, will be ground into fine powder after Endothelium Corneum Gigeriae Galli, Spora Lygodii, the Radix Et Rhizoma Rhei three flavor medicine oven dry, mix homogeneously sieves with≤100 mesh sieves, produces medicated powder I, and is standby.Getting decoctings such as Pheretima, Talcum, Herba Lysimachiae, Semen Plantaginis, Folium Pyrrosiae, Herba Salviae Chinensis, Squama Manis, Semen Vaccariae, Rhizoma Alismatis, Radix Glycyrrhizae boils 2 times; First decocts 2～3h, filters; Second decocts 1～1.5h, filters; Merge 2 times filtrate, become the thick paste shape,, sieve, produce medicated powder II with≤200 mesh sieves with pulverizing behind the thick paste vacuum normal temperature drying at concentrating under reduced pressure below 80C °.Reuse medicated powder I, medicated powder II are with the general one-tenth watered pill of cold boiled water.Then medicine of the present invention is dressed up pouch, every bag of 8～10g is for taking.
Instructions of taking: per day for adults 3 times, each 1 bag.
Medicine of the present invention is observed through clinical 180 people, and wherein 106 people, contrast groups 74 people are organized in treatment.Adopting the total effective rate of the treatment group of Drug therapy of the present invention is 95.3%, 65 people that wherein fully recover, 36 people that take a turn for the better, invalid 5 people; And the contrast groups total effective rate is 73%, 41 people that wherein fully recover, 13 people that take a turn for the better, invalid 20 people.
Therefore the present invention has characteristics such as clinical efficacy height, safe and reliable, easy to use, reasonable price.
Adnexa: 1, nephrolith is worn treatment urinary system calculus clinical research report
Claims (3)
1, a kind of medicine of the treatment urinary system calculus of forming by Chinese medicine, it is characterized in that with clearing away heat-damp and promoting diuresis, fossil calculus medicine be monarch drug, being aided with the removing damp-heat in lower-JIAO, dispeling the sandstone origin cause of formation is ministerial drug, be adjuvant drug and be messenger drug with blood circulation promoting and blood stasis dispelling, broken hard eliminating stagnation medicine with heat-clearing and toxic substances removing, the property of medicine medicine that is in harmonious proportion;
Medicine of the present invention is formed, and by its weight ratio is: Endothelium Corneum Gigeriae Galli 4800～5600g, Spora Lygodii 1500～2000g, Radix Et Rhizoma Rhei 1500～2000g, Pheretima 3000～3500g, Talcum 1500～2000g, Herba Lysimachiae 4800～5600g, Semen Plantaginis 1500～2000g, Folium Pyrrosiae 1500～2000g, Herba Salviae Chinensis 1500～2000g, Squama Manis 1500～2000g, Semen Vaccariae 1500～2000g, Rhizoma Alismatis 1500～2000g, Radix Glycyrrhizae 1500～2000g.
2, the medicine of treatment urinary system calculus according to claim 1, it is characterized in that medicine optimization composition, by its weight ratio be: Endothelium Corneum Gigeriae Galli 4900～5200g, Spora Lygodii 1600～1800g, Radix Et Rhizoma Rhei 1600～1800g, Pheretima 3200～3400g, Talcum 1600～1800g, Herba Lysimachiae 4900～5200g, Semen Plantaginis 1600～1800g, Folium Pyrrosiae 1600～1800g, Herba Salviae Chinensis 1600～1800g, Squama Manis 1600～1800g, Semen Vaccariae 1600～1800g, Rhizoma Alismatis 1600～1800g, Radix Glycyrrhizae 1600～1800g.
3, the preparation method of the medicine of the described treatment urinary system calculus of a kind of claim 1 is characterized in that respectively forming medicine and is equipped with by its weight ratio, will be ground into fine powder after Endothelium Corneum Gigeriae Galli, Spora Lygodii, the Radix Et Rhizoma Rhei three flavor medicine oven dry, mix homogeneously, sieve with≤100 mesh sieves, produce medicated powder I, standby.Getting decoctings such as Pheretima, Talcum, Herba Lysimachiae, Semen Plantaginis, Folium Pyrrosiae, Herba Salviae Chinensis, Squama Manis, Semen Vaccariae, Rhizoma Alismatis, Radix Glycyrrhizae boils 2 times; First decocts 2～3h, filters; Second decocts 1～1.5h, filters; Merge 2 times filtrate, become the thick paste shape,, sieve, produce medicated powder II with≤200 mesh sieves with pulverizing behind the thick paste vacuum normal temperature drying at concentrating under reduced pressure below 80C °, again with medicated powder I, medicated powder II mixing with the general one-tenth watered pill of cold boiled water.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100440549A CN100353975C (en) | 2005-07-20 | 2005-07-20 | Medicine for treating urinary system stone disease, and its prepn. method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100440549A CN100353975C (en) | 2005-07-20 | 2005-07-20 | Medicine for treating urinary system stone disease, and its prepn. method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1723919A true CN1723919A (en) | 2006-01-25 |
| CN100353975C CN100353975C (en) | 2007-12-12 |
Family
ID=35923633
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005100440549A Expired - Fee Related CN100353975C (en) | 2005-07-20 | 2005-07-20 | Medicine for treating urinary system stone disease, and its prepn. method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100353975C (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101559146B (en) * | 2008-04-17 | 2012-03-14 | 王守东 | Oral Tonglin Paishi capsule for curing urinary calculi and preparation method thereof |
| CN103263578A (en) * | 2013-06-17 | 2013-08-28 | 贵州鸿德中药开发有限公司 | Traditional Chinese medicine for treating urinary calculus and preparation method thereof |
| CN105708935A (en) * | 2015-01-07 | 2016-06-29 | 泸州岷宏科技有限公司 | Urinary calculus decomposing pills and preparation method thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1586524A (en) * | 2004-07-25 | 2005-03-02 | 夏光福 | External medicine for treating lithiasis |
| CN1615990A (en) * | 2004-09-11 | 2005-05-18 | 丁章森 | Capsule for treating cholelithiasis |
-
2005
- 2005-07-20 CN CNB2005100440549A patent/CN100353975C/en not_active Expired - Fee Related
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101559146B (en) * | 2008-04-17 | 2012-03-14 | 王守东 | Oral Tonglin Paishi capsule for curing urinary calculi and preparation method thereof |
| CN103263578A (en) * | 2013-06-17 | 2013-08-28 | 贵州鸿德中药开发有限公司 | Traditional Chinese medicine for treating urinary calculus and preparation method thereof |
| CN103263578B (en) * | 2013-06-17 | 2014-08-20 | 贵州鸿德中药开发有限公司 | Traditional Chinese medicine for treating urinary calculus and preparation method thereof |
| CN105708935A (en) * | 2015-01-07 | 2016-06-29 | 泸州岷宏科技有限公司 | Urinary calculus decomposing pills and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100353975C (en) | 2007-12-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102526616A (en) | Chinese medicinal herb pills for treating cholecystitis and gallstone | |
| CN100353975C (en) | Medicine for treating urinary system stone disease, and its prepn. method | |
| CN100566745C (en) | The fumigation and washing agent of treatment gynecological inflammation | |
| CN102379996A (en) | External Chinese medicament for treating scabies | |
| CN103263601A (en) | Chinese herbal preparation for accelerating fracture post-operation healing and preparation method of Chinese herbal preparation | |
| CN1742904A (en) | Chinese medicine for treating urinary stone and urinary system inflammation, and production method thereof | |
| CN103432485B (en) | Chinese medicinal preparation for treating urinary calculus and preparation method | |
| CN104116953A (en) | Traditional Chinese medicament for treating lithangiuria | |
| CN101637548B (en) | Medicine for treating kidney stone and preparation method thereof | |
| CN100579544C (en) | Chinese medicament preparation for treating cholecystitis and gall-stone as well as preparation method thereof | |
| CN100534471C (en) | Chinese medicine for treating rheumatoid arthritis | |
| CN102309552A (en) | Chinese medicinal decoction for treating urolithiasis | |
| CN103007227B (en) | Drug for treating kidney calculus, and preparation method thereof | |
| CN106237155A (en) | A kind of decoction medicine treating exogenous high fever and preparation method thereof | |
| CN101647880A (en) | Medicament for treating appendicitis and preparation method thereof | |
| CN102274416B (en) | Traditional Chinese medicine for treating acute nephritis | |
| CN105079721A (en) | Traditional Chinese medicine composition for treating osteoarthritis and preparing method thereof | |
| CN100394925C (en) | Chinese medicinal composition for treating rheumatism rheumatoid arthritis and osteosis | |
| CN102671027B (en) | Traditional Chinese medicine for curing calculi in urinary system | |
| CN103536822B (en) | The medicine for the treatment of hyperosteogeny and prolapse of lumbar intervertebral disc | |
| CN102940674B (en) | Medicine composition for treating benign prostatic hyperplasia | |
| CN102671132A (en) | Traditional Chinese medicine combination for treating atonic constipation | |
| CN102048871A (en) | Formula of traditional Chinese medicine for treating renal calculus | |
| CN109260307B (en) | A Chinese medicinal composition with calculus removing effect, and its preparation method | |
| CN106177250A (en) | A kind of Chinese medicine composition treating chronic nephritis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20071212 Termination date: 20100720 |